105 related articles for article (PubMed ID: 28724271)
1. Comparison of Histopathologic Features of Endometrial Cancer Based on Menopausal Status and Safety of Ovarian Preservation in Premenopausal Women.
Kan O; Alkilic A; Cetindag Aydın EN; Koyuncu K; Taskin S; Ortac F
Acta Med Iran; 2017 May; 55(5):311-315. PubMed ID: 28724271
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for ovarian involvement in young and premenopausal endometrioid endometrial cancer patients.
Li J; Zhu Q; Yang B; Ning C; Liu X; Luo X; Chen X
Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():151-154. PubMed ID: 29408747
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of ovarian preservation in patients with early stage endometrial carcinoma.
Lee TS; Jung JY; Kim JW; Park NH; Song YS; Kang SB; Lee HP
Gynecol Oncol; 2007 Jan; 104(1):52-7. PubMed ID: 16887175
[TBL] [Abstract][Full Text] [Related]
4. Coexisting ovarian malignancy in young women with endometrial cancer.
Walsh C; Holschneider C; Hoang Y; Tieu K; Karlan B; Cass I
Obstet Gynecol; 2005 Oct; 106(4):693-9. PubMed ID: 16199623
[TBL] [Abstract][Full Text] [Related]
5. Coexisting ovarian malignancy in patients with clinical stage I endometrial carcinoma.
Akbayır O; Kuru O; Goksedef P; Numanoglu C; Corbacıoglu A; Cetin A
Arch Gynecol Obstet; 2012 Nov; 286(5):1241-5. PubMed ID: 22688443
[TBL] [Abstract][Full Text] [Related]
6. Ovarian involvement in endometrioid adenocarcinoma of uterus.
Lin KY; Miller DS; Bailey AA; Andrews SJ; Kehoe SM; Richardson DL; Lea JS
Gynecol Oncol; 2015 Sep; 138(3):532-5. PubMed ID: 26186908
[TBL] [Abstract][Full Text] [Related]
7. Ovarian preservation in young women with endometrial cancer of endometrioid histology.
Kinjyo Y; Kudaka W; Ooyama T; Inamine M; Nagai Y; Aoki Y
Acta Obstet Gynecol Scand; 2015 Apr; 94(4):430-4. PubMed ID: 25603833
[TBL] [Abstract][Full Text] [Related]
8. Risk-stratifying clinicopathologic criteria for ovarian preservation in premenopausal women with early stage low-risk endometrial cancer.
Khadraoui W; Tierney C; Chung S; Mutlu L; Lu L; Azodi M; Ratner E; Menderes G
Int J Gynaecol Obstet; 2020 Sep; 150(3):385-391. PubMed ID: 32506422
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of ovarian preservation in a cohort of premenopausal women with early-stage endometrial cancer: a Korean Gynecologic Oncology Group study.
Lee TS; Lee JY; Kim JW; Oh S; Seong SJ; Lee JM; Kim TJ; Cho CH; Kim SM; Park CY
Gynecol Oncol; 2013 Nov; 131(2):289-93. PubMed ID: 23994534
[TBL] [Abstract][Full Text] [Related]
10. Outcome of ovarian preservation during surgical treatment for endometrial cancer: A Taiwanese Gynecologic Oncology Group study.
Lau HY; Chen MY; Ke YM; Chen JR; Chen IH; Liou WS; Fu HC; Chang CC; Hsu KF; Wang KL
Taiwan J Obstet Gynecol; 2015 Oct; 54(5):532-6. PubMed ID: 26522105
[TBL] [Abstract][Full Text] [Related]
11. Synchronous endometrial and ovarian carcinomas: predictors of risk and associations with survival and tumor expression profiles.
Kelemen LE; Rambau PF; Koziak JM; Steed H; Köbel M
Cancer Causes Control; 2017 May; 28(5):447-457. PubMed ID: 28194593
[TBL] [Abstract][Full Text] [Related]
12. Molecular and pathologic data to guide selection of patients with endometrioid endometrial cancer for ovarian preservation.
Manning-Geist BL; Rios-Doria E; Liu YL; Ellenson LH; Zhou QC; Iasonos A; Leitao MM; Abu-Rustum NR; Weigelt B; Mueller JJ
Int J Gynecol Cancer; 2024 May; 34(5):697-704. PubMed ID: 38508587
[TBL] [Abstract][Full Text] [Related]
13. Synchronous primary cancers of the endometrium and ovary in young women: a Korean Gynecologic Oncology Group Study.
Song T; Seong SJ; Bae DS; Suh DH; Kim DY; Lee KH; Lim MC; Lee TS
Gynecol Oncol; 2013 Dec; 131(3):624-8. PubMed ID: 24051220
[TBL] [Abstract][Full Text] [Related]
14. Non-sex cord-stromal ovarian tumors frequently produce and secrete estrogen in postmenopausal women: impact on bone metabolism and abnormal endometrial histology.
Matsumura S; Ohta T; Takahashi T; Yamazaki T; Takahashi K; Kurachi H
J Clin Endocrinol Metab; 2013 Jul; 98(7):2775-82. PubMed ID: 23780377
[TBL] [Abstract][Full Text] [Related]
15. Safety of ovarian preservation in young patients with early-stage endometrial cancer: a retrospective study and meta-analysis.
Sun C; Chen G; Yang Z; Jiang J; Yang X; Li N; Zhou B; Zhu T; Wei J; Weng D; Ma D; Wang C; Kong B
Fertil Steril; 2013 Sep; 100(3):782-7. PubMed ID: 23830105
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic efficacy of MRI for pre-operative assessment of ovarian malignancy in endometrial carcinoma: A decision tree analysis.
Xu X; Li N; Chen Y; Ouyang H; Zhao X; Zhou J
Magn Reson Imaging; 2019 Apr; 57():285-292. PubMed ID: 30580078
[TBL] [Abstract][Full Text] [Related]
17. Preoperative predictive factor analysis of ovarian malignant involvement in premenopausal patients with clinical stage I endometrioid endometrial carcinoma.
Chen Q; Feng Y; Wang W; Lv W; Li B
Sci Rep; 2021 Jan; 11(1):1219. PubMed ID: 33441576
[TBL] [Abstract][Full Text] [Related]
18. Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases.
Soliman PT; Slomovitz BM; Broaddus RR; Sun CC; Oh JC; Eifel PJ; Gershenson DM; Lu KH
Gynecol Oncol; 2004 Aug; 94(2):456-62. PubMed ID: 15297188
[TBL] [Abstract][Full Text] [Related]
19. A preoperative prediction model for predicting coexisting adnexa malignancy of patients with G1/G2 endometrioid endometrial cancer.
Shen L; Xie L; Li R; Shan B; Liang S; Tian W; Wang H; Ren Y
Gynecol Oncol; 2020 Nov; 159(2):402-408. PubMed ID: 32847677
[TBL] [Abstract][Full Text] [Related]
20. Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset.
Garg K; Shih K; Barakat R; Zhou Q; Iasonos A; Soslow RA
Am J Surg Pathol; 2009 Dec; 33(12):1869-77. PubMed ID: 19898223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
